HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Case selection for cardiac resynchronization in atrial fibrillation.

Abstract
Remarkably little evidence exists that cardiac resynchronization therapy (CRT) is effective in patients who have atrial fibrillation (AF) but who otherwise seem suitable for this treatment. The landmark trials of CRT generally excluded patients with AF because atrioventricular (AV) resynchronization was considered a possibly important mechanism by which CRT might deliver its benefits. The only landmark trial that included many patients with AF confirmed marked benefit among patients in sinus rhythm but no benefit among those with AF. Evidence is lacking that biventricular rather than AV resynchronization is an important mechanism for delivering the benefits of CRT.
AuthorsJohn G F Cleland, Freidoon Keshavarzi, Pierpaolo Pellicori, Benjamin Dicken
JournalHeart failure clinics (Heart Fail Clin) Vol. 9 Issue 4 Pg. 461-74, ix (Oct 2013) ISSN: 1551-7136 [Print] United States
PMID24054479 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
CopyrightCopyright © 2013 Elsevier Inc. All rights reserved.
Topics
  • Atrial Fibrillation (complications, physiopathology, therapy)
  • Cardiac Resynchronization Therapy (methods)
  • Heart Failure (etiology, physiopathology, prevention & control)
  • Heart Rate (physiology)
  • Humans
  • Patient Selection
  • Practice Guidelines as Topic
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: